Pfizer & Pharmacia Merger

3,398 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
3,398
On SlideShare
0
From Embeds
0
Number of Embeds
5
Actions
Shares
0
Downloads
85
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Pfizer & Pharmacia Merger

  1. 1. Pfizer and Pharmacia Merger
  2. 2. Pfizer And Pharmacia Merger• Pfizer : Vishwajeet Aher• Pharmacia : Shreyas Alai• Merger : Vaibhav Agrawal
  3. 3. Pfizer Inc.• American Multinational Pharmaceutical Corporation. (HQ - New York City)• Largest Pharmaceutical corporation in terms of revenues.• Revenue - 67.42 Bn USD• Income - 10.23 Bn USD• Assets - 180 Bn USD• Market Cap. – 201.59 Bn USD Corp.flv
  4. 4. Products• More than 40 Genuine products in market under its title• Famous Products - Lipitor Difflucan Zithromax Celebrex Bextra• Feldene ( Piroxicam )
  5. 5. History & Development• Est. : 1849 by C. Pfizer & C. Erhart• HQ : Brooklyn• Chemicals Company• Santonin – Antiparasitic• 1880 – Citric Acid• WW1• Fermentation• WW2 & Penicillin
  6. 6. • 1950 : Terramycin• 1950s, Pfizer was established in Belgium, Brazil, Canada,Cuba, Iran, Mexico, Panama, Puerto Rico, Turkey and theUnited Kingdom.• During the 1980s and 1990s Pfizer underwent a period ofgrowth sustained by the discovery and marketingof Zoloft, Lipitor, Norvasc,Zithromax, Aricept, Diflucan.
  7. 7. Allegations• Quigley Co.• Bjork–Shiley heart valve• Off-label promotional practices• Nigeria• Inorganic Growth: - Warner- Lambert - Wyeth - Pharmacia - King Pharmaceutical
  8. 8. History & Development• Est. – 1911 in Stockholm, Sweden by Gustav Felix• Phospho – Energon• WW2 – Polysaccharide dextran• 1943 – Macrodex• 1959 – Gel Filtration, Sephadex• 1986 – Pharmacia Biotech.• 1995 - Pharmacia Upjhon, London• 1999 – Pharmacia & Upjhon merge with MonsantoCompany
  9. 9. Sequence of Mergers G. D. Serale & Company 1985 2002 Monsanto Company 2000Pharmacia Biotech aquired by Upjhon,1995
  10. 10. Merger• Pharmacia Corp. aquired by Pfizer on July 2003• Deal was finalized for 60 Bn USD• Largest merger in Global Pharmaceutical History• Reasons1.Marketing rights for Celebrex2.To position Pfizer as a long term global leader inpharmaceutical industry3.To strengthen research in oncology medicines.
  11. 11. Post Merger Consequences• 12 Products of celebrex with annual revenue of more than 1 Bn USD• Enhanced therapeutic portfolio of Pfizer in oncology,opthalmology and endocrinology• Increased share prices of Pfizer• Closure of some of Pharmacia’s facilities and job cuts
  12. 12. Thank You ..! &Questions …..IfAny ?- Vishwajeet Aher/02- Shreyas Alai/03- Vaibhav Agrawal/01 12

×